Defense Production Act – COVID-19 Tests Deployed

President Biden signed the Defense Production Act (DPA) to contract with six diagnostics manufacturers in the coming weeks to rapidly produce inexpensive and reliable coronavirus tests for home and clinic use. The goal is to provide 61 million point-of-care or at-home tests by the end of this summer.   The FDA has granted three at-home tests to date, only one of which does not require a prescription.